Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
7.35
Nov 13 • 3:59 PM ET Dollar change+2.01 Percentage change(37.64%)
Aftermarket Close
7.14
Aftermarket • 7:53 PM ET Dollar change-0.21 Percentage change(-2.86%)
Today, 10:39 AMSBC Medical beats Q3 2026 revenue estimates with $59m, up 35% YoY, as adjusted EBITDA rises 66% to $28m and margin expands 900 bps
Index
RUT
Market Cap
755.92M
Enterprise Value
613.84M
Income
51.89M
Sales
190.40M
Book/sh
2.80
Cash/sh
1.97
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
863
IPO
Sep 26, 2022
P/E
14.53
Forward P/E
13.83
PEG
4.96
P/S
3.97
P/B
2.63
P/C
3.73
P/FCF
6.66
EV/EBITDA
7.71
EV/Sales
3.22
Quick Ratio
3.63
Current Ratio
3.67
Debt/Eq
0.15
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
0.51
EPS next Y
0.53
EPS next Q
0.12
EPS this Y
-6.36%
EPS next Y
13.52%
EPS next 5Y
2.79%
EPS past 3/5Y
138.04% -
Sales past 3/5Y
- -
EPS Y/Y TTM
20.31%
Sales Y/Y TTM
6.69%
EPS Q/Q
22.50%
Sales Q/Q
35.13%
Insider Own
81.55%
Insider Trans
0.00%
Inst Own
4.79%
Inst Trans
129.13%
ROA
13.91%
ROE
19.41%
ROIC
16.41%
Gross Margin
71.79%
Oper. Margin
39.89%
Profit Margin
27.26%
SMA20
35.23%
SMA50
43.38%
SMA200
85.33%
Trades
Shs Outstand
102.58M
Shs Float
18.97M
52W High
5.79 26.88%
52W Low
2.78 164.39%
Volatility
7.54% 5.85%
ATR (14)
0.38
RSI (14)
78.32
Beta
0.52
Rel Volume
8.29
Avg Volume
206.34K
Volume
1,711,574
Perf Week
45.83%
Perf Month
38.68%
Perf Quarter
101.37%
Perf Half Y
147.47%
Perf YTD
70.53%
Perf Year
118.75%
Perf 3Y
-30.86%
Perf 5Y
-
Perf 10Y
-
Prev Close
5.34
Price
7.35
Change %
37.64%
Consensus
Strong Buy
Avg. Price Target
$9.25
Implied Upside
+25.9%
Analysts1incl. previous ratings
Rating Distribution1 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Mar 06, 2026Initiated
BBTIG Research
Buy$8+8.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aikawa YoshiyukiChairman and CEOApr 28 '26Sale3.02465,0001,405,46278,839,460Apr 29 09:38 PM
Aikawa YoshiyukiChairman and CEOApr 21 '26Sale3.023,100,0009,369,75079,304,460Apr 23 08:00 PM
Aikawa YoshiyukiChairman and CEOMar 06 '26Sale2.124,422,9009,376,548861,600Mar 10 09:54 PM
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company was founded on January 20, 2023 and is headquartered in Irvine, CA.
Chairman & CEODr. Yoshiyuki Aikawa
COOMr. Yuya Yoshida
Chief Strategy OfficerMs. Miki Yamazaki
Principal Accounting OfficerMr. Ryoji Murata
Chief Marketing OfficerMr. Shinya Inoue